DAC Plots To Come From Behind In Small Cell Lung Cancer ADC Race
As DAC plans a Phase III registrational study in China for its CD56-targeting antibody-drug conjugate DXC006 for second- or later-line ES-SCLC, it sees low toxicity as a potential key advantage for the relative latecomer.
Scrip - July 16, 2026

After Decades Of Regulatory Stasis, CMS And CDC Signal CLIA Update May Be Coming
A joint CMS-CDC RFI on clinical lab regulations asks for stakeholder input across four major areas, including breath testing, lab procedures, emergency preparedness and specialized testing.
Medtech Insight - July 15, 2026

India-UK Trade Deal: Lower Duties, Big Ambitions But Circumvention Still Unresolved
A landmark trade agreement between India and the UK takes effect today, cutting tariffs on medical devices in both directions — but with a $97m trade imbalance to close and circumvention risks already flagged by industry, the deal's medtech promise comes with significant caveats attached.
Medtech Insight - July 15, 2026

FDA Warning Letters to ZIIP and Nihon Kohden Cite Device Marketing and Software Compliance Issues
In two separate warning letters, the FDA cited ZIIP for alleged marketing authorization, promotional claims, and quality system controls violations related to its facial devices, and Nihon Kohden Digital Health Solutions for modifications to its patient monitoring software.
Medtech Insight - July 15, 2026

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success
£28m investment in AI diagnostics for the UK health service is welcome, but only one piece of the puzzle in reducing wait times.
Medtech Insight - July 15, 2026

SpotitEarly Bets On Dogs, Breath And AI For Early Cancer Detection
SpotitEarly CEO Shlomi Madar makes the case for breath-based cancer screening — trained beagles, sensors and AI reading VOCs — as GRAIL's NHS-Galleri miss reopens how MCED tests should be judged. He touts early-stage sensitivity, a de novo path and near-term PINK data.
Medtech Insight - July 15, 2026

Philips Targets Rural Hospitals And Surgery Centers With Modular PM 6000
Philips has launched the IntelliVue PM 6000 Series with a clear target: rural hospitals and ambulatory surgery centers handling more complex patients with fewer staff and shrinking budgets — facilities being asked to match large-system standards with a fraction of the resources.
Medtech Insight - July 15, 2026

AAIC Data Raises Promise Of Alzheimer’s Prognoses From Blood
Harvard Medical School study finds that p-tau217 blood tests were able to predict risk of developing cognitive impairment over 10 years.
Medtech Insight - July 15, 2026

House Democrats Want GAO Study Of US FDA User Fee Spending On Layoffs
Rep. Frank Pallone questioned whether user fees could be spent on severance and other costs related to staff departures.
HBW Insight - July 16, 2026

US OTC Monograph Guidance On Formal Meetings Adds IND Studies, Clarifies ‘Joint’ Requests
Final guidance features revisions from 2022 draft including addressing meetings with agency officials to obtain advice on IND applications to support determinations of whether an OTC drug is GRASE, and clarification of eligible participants in “joint meetings.”
HBW Insight - July 16, 2026

Givaudan, IFF Invest In Scent-Extending Tech; Fragrance Roundup
Givaudan is investing in encapsulation technology that will enhance scent performance, as International Flavors & Fragrances focuses on light-activated fragrance technology and dsm-firmenich rolls out its immersive art-and-fragrance installation.
HBW Insight - July 16, 2026

Formycon Partners With OneSource For Biosimilar Manufacturing
Formycon has signed a manufacturing partnership with India-based CDMO OneSource, gaining integrated drug substance and drug product capabilities as it executes its FYB4Growth strategy.
Generics Bulletin - July 15, 2026

Actavis Fails To Escape Key Generics Collusion Claims
A federal judge has preserved most product-specific claims against Actavis, finding enough evidence of alleged coordination over pricing, customers and market share for a jury to consider.
Generics Bulletin - July 15, 2026

Bisoprolol And Ezetimibe Surge In A Busy June For UK Rises
Two presentations of bisoprolol topped our Biggest Risers table for June – but the anticoagulant was far from the only generic experiencing steep UK price rises last month, with recently-launched ezetimibe increasing its average price by more than ten times.
Generics Bulletin - July 15, 2026

ZS’s Roffman: China Leads The Way On Patient Trust In AI
A three-country survey of healthcare stakeholders in the US, Germany and China indicates that patients’ confidence in healthcare AI tools now almost matches the trust they have in healthcare professionals. Jon Roffman, ZS global head of biopharma, says attitudes to AI are changing fast.
In Vivo - July 15, 2026